Quick Answer
LISATA THERAPEUTICS, INC. reported Long Term Debt of $0.00 for the year ending 2017.
- LISATA THERAPEUTICS, INC. showed a decrease of -100.0% in Long Term Debt from 2016 to 2017.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 22, 2018.
- XBRL data for this metric is available from 2012 to 2017 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $15.00 million | Q1 2015: $12.76 million | Q2 2015: $13.64 million | Q3 2015: $12.25 million | Q1 2016: $7.49 million | Q2 2016: $3.64 million | Q3 2016: $3.33 million | Q1 2017: $1.70 million | Q2 2017: $0.00 | Q3 2017: $0.00.
- Historical annual values: Fiscal year 2017: $0.00 | Fiscal year 2016: $2.52 million | Fiscal year 2015: $10.83 million | Fiscal year 2014: $13.89 million | Fiscal year 2014: $0.00 | Fiscal year 2013: $0.00 | Fiscal year 2013: $3.02 million | Fiscal year 2012: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: